comparemela.com
Home
Live Updates
Distinguish Trial - Breaking News
Pages:
Latest Breaking News On - Distinguish trial - Page 1 : comparemela.com
Leap Therapeutics Provides Update on BeiGene Option Agreement for DKN-01
/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced.
United kingdom
Matthew deyoung
Douglase onsi
Prnewswire leap therapeutics inc
Drug administration
Leap therapeutics inc
Distinguish trial
Exclusive option
License agreement
Chief executive officer
Flame biosciences
Leap therapeutics
Nasdaq global
Annual report
Leap Therapeutics to Present Updated Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab and Preclinical Data in Colorectal Cancer Models at the SITC Annual Meeting
/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today.
United states
United kingdom
New zealand
Matthew deyoung
Douglase onsi
Prnewswire leap therapeutics inc
Securities exchange
Beigene ltd
Society of immunotherapy
Leap therapeutics inc
Distinguish study
Annual meeting
Defiance study
Presentation details
Investigational therapy
Gastroesophageal adenocarcinoma
vimarsana © 2020. All Rights Reserved.